All companies
Hemab Therapeutics Holdings Inc logo

Hemab Therapeutics Holdings Inc

IPO Upcoming
Best valuation 0 sources

Official IPO

Priced· NASDAQ Global Select
Expected
May 1, 2026
Final price
$18.00
Shares offered
16,750,000
Raise
$301.5M

Sources: nasdaq

No quoted sources for this company yet.
IPO Tracker — pre-IPO & IPO assets, regrouped.

Aggregated data, not investment advice.